Overview
Kara-louise Royle practices practicing medicine in Leeds, United Kingdom.
Royle is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Multiple Myeloma and Renal Cell Carcinoma (RCC).
They are actively involved in clinical research, co-authoring 14 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kara-louise Royle
Is Kara-louise Royle a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Kara-louise Royle is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kara-louise Royle participate in research or clinical trials?
Yes. Kara-louise Royle has published 14 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Kara-louise Royle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Multiple MyelomaRoyle isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Renal Cell Carcinoma (RCC)Royle isExperienced. Learn about Renal Cell Carcinoma (RCC).